PMID- 25640838 OWN - NLM STAT- MEDLINE DCOM- 20150506 LR - 20220310 IS - 1090-2104 (Electronic) IS - 0006-291X (Linking) VI - 458 IP - 1 DP - 2015 Feb 27 TI - Mitochondrial Ca(2)(+) uniporter is critical for store-operated Ca(2)(+) entry-dependent breast cancer cell migration. PG - 186-93 LID - S0006-291X(15)00131-X [pii] LID - 10.1016/j.bbrc.2015.01.092 [doi] AB - Metastasis of cancer cells is a complicated multistep process requiring extensive and continuous cytosolic calcium modulation. Mitochondrial Ca(2+) uniporter (MCU), a regulator of mitochondrial Ca(2+) uptake, has been implicated in energy metabolism and various cellular signaling processes. However, whether MCU contributes to cancer cell migration has not been established. Here we examined the expression of MCU mRNA in the Oncomine database and found that MCU is correlated to metastasis and invasive breast cancer. MCU inhibition by ruthenium red (RuR) or MCU silencing by siRNA abolished serum-induced migration in MDA-MB-231 breast cancer cells and reduced serum- or thapsigargin (TG)-induced store-operated Ca2+ entry (SOCE). Serum-induced migrations in MDA-MB-231 cells were blocked by SOCE inhibitors. Our results demonstrate that MCU plays a critical role in breast cancer cell migration by regulating SOCE. CI - Copyright (c) 2015 Elsevier Inc. All rights reserved. FAU - Tang, Shihao AU - Tang S AD - Department of Occupational Health and Occupational Medicine, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong, China; Guangzhou No.12 Hospital, Guangzhou, China. FAU - Wang, Xubu AU - Wang X AD - Department of Occupational Health and Occupational Medicine, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong, China. FAU - Shen, Qiang AU - Shen Q AD - Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. FAU - Yang, Xinyi AU - Yang X AD - Department of Occupational Health and Occupational Medicine, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong, China. FAU - Yu, Changhui AU - Yu C AD - Department of Occupational Health and Occupational Medicine, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong, China. FAU - Cai, Chunqing AU - Cai C AD - Department of Occupational Health and Occupational Medicine, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong, China. FAU - Cai, Guoshuai AU - Cai G AD - Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. FAU - Meng, Xiaojing AU - Meng X AD - Department of Occupational Health and Occupational Medicine, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong, China. Electronic address: xiaojingmeng@smu.edu.cn. FAU - Zou, Fei AU - Zou F AD - Department of Occupational Health and Occupational Medicine, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong, China. Electronic address: zoufei616@163.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150129 PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Calcium Channel Blockers) RN - 0 (Calcium Channels) RN - 0 (Imidazoles) RN - 0 (mitochondrial calcium uniporter) RN - 11103-72-3 (Ruthenium Red) RN - 67526-95-8 (Thapsigargin) RN - I61V87164A (1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole) RN - SY7Q814VUP (Calcium) SB - IM MH - Breast Neoplasms/genetics/metabolism/*pathology MH - Calcium/*metabolism MH - Calcium Channel Blockers/pharmacology MH - Calcium Channels/*genetics/*metabolism MH - Cell Line, Tumor MH - Cell Movement/drug effects MH - Female MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Imidazoles/pharmacology MH - Mitochondria/drug effects/metabolism MH - Ruthenium Red/pharmacology MH - Thapsigargin/pharmacology OTO - NOTNLM OT - Breast tumor OT - MCU OT - Migration OT - SOCE EDAT- 2015/02/03 06:00 MHDA- 2015/05/07 06:00 CRDT- 2015/02/03 06:00 PHST- 2015/01/11 00:00 [received] PHST- 2015/01/20 00:00 [accepted] PHST- 2015/02/03 06:00 [entrez] PHST- 2015/02/03 06:00 [pubmed] PHST- 2015/05/07 06:00 [medline] AID - S0006-291X(15)00131-X [pii] AID - 10.1016/j.bbrc.2015.01.092 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2015 Feb 27;458(1):186-93. doi: 10.1016/j.bbrc.2015.01.092. Epub 2015 Jan 29.